In addition, preclinical studies with dual-acting GIP/GLP-2 hybrid peptides demonstrate particular therapeutic promise for bone disorders, which merits further clinical exploration
Real needle-free GLP-1 exists: the Wegovy oral tablet (oral semaglutide 25 mg, FDA-approved December 2025, 13.6% weight loss in the OASIS 4 trial) and experimental microneedle patches from Daewoong Therapeutics (80% bioavailability in a 70-person Phase 1 study, 2028-2030 market estimate)
P is being seen for falls, which already places her at elevated fracture risk
Take Action For questions about GLP-1 medications and overdoses, call Poison Help at 1-800-222-1222
Roughly 6 percent of Americans currently take a GLP-1 drug
Typically, you may notice improvements in appetite control within two to four weeks, and more significant weight loss after several weeks of consistent use